Ikena Oncology, Inc.
IKNA
$1.14
-$0.01-0.87%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -41.71M | -49.23M | -59.60M | -66.71M | -70.09M |
| Total Depreciation and Amortization | 358.00K | 490.00K | 706.00K | 858.00K | 1.01M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 5.07M | 6.72M | 9.23M | 9.85M | 10.16M |
| Change in Net Operating Assets | -1.98M | -3.98M | -11.90M | -16.62M | -19.34M |
| Cash from Operations | -38.26M | -46.00M | -61.56M | -72.62M | -78.26M |
| Capital Expenditure | -- | -- | -262.00K | -262.00K | -262.00K |
| Sale of Property, Plant, and Equipment | 375.00K | 435.00K | 431.00K | 241.00K | 60.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 21.39M | -35.34M | -15.16M | 7.47M | 26.41M |
| Cash from Investing | 21.77M | -34.90M | -14.99M | 7.45M | 26.21M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 0.00 | 0.00 | 37.67M |
| Repurchase of Common Stock | -- | -- | 0.00 | -108.00K | -771.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 60.00K | 39.09M | 39.09M |
| Cash from Financing | -- | -- | 60.00K | 38.98M | 75.98M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -16.50M | -80.91M | -76.49M | -26.19M | 23.93M |